BR112012008040A2 - composição antimicrobiana aquosa - Google Patents

composição antimicrobiana aquosa

Info

Publication number
BR112012008040A2
BR112012008040A2 BR112012008040A BR112012008040A BR112012008040A2 BR 112012008040 A2 BR112012008040 A2 BR 112012008040A2 BR 112012008040 A BR112012008040 A BR 112012008040A BR 112012008040 A BR112012008040 A BR 112012008040A BR 112012008040 A2 BR112012008040 A2 BR 112012008040A2
Authority
BR
Brazil
Prior art keywords
antimicrobial composition
aqueous antimicrobial
nrtis
compositions
disclosed
Prior art date
Application number
BR112012008040A
Other languages
English (en)
Other versions
BR112012008040B1 (pt
Inventor
David M Phillips
Mitchell Thorn
Naomi Rutenberg
Robin A Maguire
Original Assignee
Population Council Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Population Council Inc filed Critical Population Council Inc
Publication of BR112012008040A2 publication Critical patent/BR112012008040A2/pt
Publication of BR112012008040B1 publication Critical patent/BR112012008040B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/731—Carrageenans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"composição antimicrobiana aquosa" são expostas composições para inibir a transmissão de uma infecção sexualmente transmitida, que contém um ou mais microbicidas polianiônicos, tais que os carragenanos, incluindo um carragenano lambda, assim como sais de metal solúvel em água e agentes antivirais, que compreendem nnrtis e nrtis. são também expostos métodos para a produção e o uso das composições.
BR112012008040A 2009-10-06 2010-10-04 composição antimicrobiana aquosa BR112012008040B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12/587,405 US8367098B2 (en) 2002-04-30 2009-10-06 Unique combinations of antimicrobial compositions
PCT/US2010/051303 WO2011044034A1 (en) 2009-10-06 2010-10-04 Carrageenan-containing aqueous antimicrobial compositions

Publications (2)

Publication Number Publication Date
BR112012008040A2 true BR112012008040A2 (pt) 2016-03-01
BR112012008040B1 BR112012008040B1 (pt) 2019-12-24

Family

ID=43036273

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012008040A BR112012008040B1 (pt) 2009-10-06 2010-10-04 composição antimicrobiana aquosa

Country Status (15)

Country Link
US (1) US8367098B2 (pt)
EP (1) EP2485710B1 (pt)
JP (1) JP5911425B2 (pt)
CN (1) CN102665677B (pt)
AU (1) AU2010303721B2 (pt)
BR (1) BR112012008040B1 (pt)
CA (1) CA2775603C (pt)
CO (1) CO6531457A2 (pt)
ES (1) ES2550815T3 (pt)
IN (1) IN2012DN02879A (pt)
MX (1) MX337376B (pt)
RU (1) RU2540423C2 (pt)
UA (1) UA109117C2 (pt)
WO (1) WO2011044034A1 (pt)
ZA (1) ZA201202526B (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8541556B1 (en) 2012-03-02 2013-09-24 Empire Technology Development Llc Lignin derivatives and uses thereof
US9095142B2 (en) 2012-06-28 2015-08-04 Empire Technology Development Llc Lignin derivatives having polycations and uses thereof
WO2014123880A1 (en) * 2013-02-05 2014-08-14 The Population Council, Inc. Intravaginal ring for the delivery of unique combinations of antimicrobial compositions
JP6284956B2 (ja) 2013-02-19 2018-02-28 ジョンソン・アンド・ジョンソン・コンシューマー・インコーポレイテッド 瘢痕組織の外観及び形成を改善するための方法並びに組成物
CN106163539A (zh) * 2014-01-28 2016-11-23 人口委员会股份有限公司 用于预防性传播感染的组合产品
EP3204016B1 (en) * 2014-10-06 2021-08-25 Algamed Therapeutics (A.M.T) Ltd. Compositions comprising sulfated polysaccharides and uses thereof
US10195169B2 (en) 2014-12-19 2019-02-05 Good Clean Love, Inc. Systems and methods for bio-matching gels, creams and lotions
US9470676B2 (en) 2014-12-19 2016-10-18 Good Clean Love, Inc. Systems and methods for bio-matching gels, creams and lotions
US10952979B2 (en) 2014-12-19 2021-03-23 Good Clean Love, Inc. Topical fertility promoting product and manufacturing method
US10485823B2 (en) * 2016-04-18 2019-11-26 Bioleaders Corporation Method for treating cervical intraepithelial neoplasia using poly-gamma- glutamic acid
US10688043B1 (en) 2018-03-20 2020-06-23 Mario Elmen Tremblay Personal lubricants comprising lambda-carrageenan
US12036313B2 (en) 2018-03-20 2024-07-16 Lanvira, Llc Personal lubricants comprising lambda-carrageenan
US12043598B2 (en) 2018-03-20 2024-07-23 Lanvira, Llc Condoms lubricated with antiviral lubricious compositions containing lambda-carrageenan
KR20210020014A (ko) 2018-05-10 2021-02-23 마리오 엘먼 트렘블레이 람다-카라기난을 포함하는 윤활 기질
KR101995376B1 (ko) * 2018-08-20 2019-07-02 한미약품 주식회사 카라기난을 유효성분으로 포함하는 항-바이러스 조성물
WO2023243525A1 (ja) * 2022-06-14 2023-12-21 株式会社ヤクルト本社 抗菌剤ならびに抗ウイルス剤およびそれらの用途

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3626054A (en) * 1967-10-25 1971-12-07 Bard Hamilton Co Inc Lupus erythematosus skin test
JPS522983B2 (pt) * 1973-06-05 1977-01-25
US4356264A (en) * 1980-04-11 1982-10-26 International Minerals & Chemical Corp. Zinc-containing antibiotic agents
US4532128A (en) * 1981-09-15 1985-07-30 Dynapol Quaternary ammonium group-containing polymers having antimicrobial activity
DK171716B1 (da) 1982-03-12 1997-04-07 Pharmacia & Upjohn Ab Fremgangsmåde til fremstilling af et kompleks af carrageenan og emepronium, doxycyklin eller propranolol
US5009867A (en) * 1984-10-09 1991-04-23 Kraft General Foods, Inc. C-gel composite pizza snack kit
US4783446A (en) 1985-11-22 1988-11-08 Neushul Mariculture Incorporated Method for the treatment of AIDS virus and other retroviruses
EP0240098A3 (en) * 1986-04-04 1989-05-10 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Oligo and polysaccharides for the treatment of diseases caused by retroviruses
EP0293826A3 (en) 1987-06-02 1989-05-10 Stichting REGA V.Z.W. Therapeutic and prophylactic application of sulfated polysaccharides against aids
US4983393A (en) * 1987-07-21 1991-01-08 Maximed Corporation Intra-vaginal device and method for sustained drug release
US5272261A (en) * 1989-01-11 1993-12-21 Merrell Dow Pharmaceuticals Inc. Preparation of sulfated polysaccharide fractions
US5066413A (en) * 1989-04-04 1991-11-19 Creative Products Resource Associates, Ltd. Gelled, dryer-added fabric-modifier sheet
US5599551A (en) * 1989-06-06 1997-02-04 Kelly; Patrick D. Genital lubricants containing zinc as an anti-viral agent
US5208031A (en) * 1989-06-06 1993-05-04 Kelly Patrick D Sexual lubricants containing zinc as an anti-viral agent
US5482053A (en) * 1989-06-06 1996-01-09 Kelly; Patrick D. Condom lubricants containing zinc as an anti-viral agent
US5624675A (en) * 1989-06-06 1997-04-29 Kelly; Patrick D. Genital lubricants containing zinc salts to reduce risk of HIV infection
US5785054A (en) * 1989-06-06 1998-07-28 Kelly; Patrick D. Genital lubricant with zinc salt, labelled as anti-viral agent
DE3930725A1 (de) * 1989-09-14 1991-03-21 Benckiser Gmbh Joh A Extra-milde duschgel- und haarshampoo-formulierung mit niedriger tensidkonzentration
US5980477A (en) * 1991-07-29 1999-11-09 Patrick Kelly Genital lubricants with zinc salts as anti-viral additives
WO1994015624A1 (en) 1993-01-08 1994-07-21 The Population Council Use of sulphated polysaccharides for preventing sexually transmitted diseases
US6321750B1 (en) * 1993-05-03 2001-11-27 Patrick D. Kelly Condom lubricants with zinc salts as anti-viral additives
JP2717497B2 (ja) 1993-12-28 1998-02-18 不二ラテックス株式会社 酸性多糖類被覆コンドーム
US5658893A (en) * 1995-03-29 1997-08-19 Abbott Laboratories Method for inhibition of rotavirus infection with carrageenan
US5667773A (en) * 1996-03-12 1997-09-16 Adolor Corporation Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith
US5972372A (en) * 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
GB9704022D0 (en) 1997-02-26 1997-04-16 York Rehabilitation Limited Protective barrier composition
IT1297461B1 (it) 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
GB9803770D0 (en) * 1998-02-23 1998-04-15 Unilever Plc Detergent compositions
SI1084167T2 (sl) 1998-05-18 2010-12-31 Rockwool Int Stabilizirano vodno fenolno vezivo za mineralno volno in proizvodnja proizvodov iz mineralne volne
DE69929550T8 (de) * 1998-05-21 2006-12-28 Nipro Corp. Albumin enthaltende Lösung für die Peritonealdialyse
EP1140021B1 (en) 1998-12-23 2004-08-04 Idea Ag Improved formulation for topical non-invasive application in vivo
US6239141B1 (en) * 1999-06-04 2001-05-29 Pfizer Inc. Trovafloxacin oral suspensions
US6248339B1 (en) * 1999-08-13 2001-06-19 Intimate Beauty Corporation Fragrant body lotion and cream
JP5241978B2 (ja) 1999-10-13 2013-07-17 帝國製薬株式会社 漢方ゼリー医薬組成物
US6365218B1 (en) 2000-02-04 2002-04-02 Abbott Laboratories Pediatric formula and methods for providing nutrition and improving tolerance
FR2807058B1 (fr) 2000-03-30 2002-06-14 Condat Sa Mastic de secours pour la prevention et la venue d'eau, pour les queues de tunneliers
US6248360B1 (en) * 2000-06-21 2001-06-19 International Health Management Associates, Inc. Complexes to improve oral absorption of poorly absorbable antibiotics
US7223417B2 (en) * 2000-10-27 2007-05-29 Calton Gary J Nutrient formulations
US6696071B2 (en) * 2001-11-27 2004-02-24 Patrick D. Kelly Pre-coital and post-coital rinse with anti-viral and skin-protective zinc salts
AU2003245252A1 (en) * 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
CA2384474A1 (en) 2002-04-30 2003-10-30 The Population Council, Inc. Compositions and methods for protecting against sexually transmitted diseases
US20040071679A1 (en) * 2002-10-15 2004-04-15 Claudio De Simone Identifying and treating vaginal infections
US20060147504A1 (en) * 2004-12-30 2006-07-06 Bobby Corry Feminine anti-itch cloth
JP5217136B2 (ja) * 2005-10-18 2013-06-19 大正製薬株式会社 直腸、尿道および膣適用用半固形状製剤。

Also Published As

Publication number Publication date
IN2012DN02879A (pt) 2015-07-24
JP2013506712A (ja) 2013-02-28
RU2540423C2 (ru) 2015-02-10
ZA201202526B (en) 2013-05-29
RU2012118600A (ru) 2013-11-20
CA2775603A1 (en) 2011-04-14
EP2485710B1 (en) 2015-07-22
AU2010303721B2 (en) 2014-05-01
CN102665677A (zh) 2012-09-12
JP5911425B2 (ja) 2016-04-27
BR112012008040B1 (pt) 2019-12-24
CN102665677B (zh) 2014-06-18
AU2010303721A1 (en) 2012-05-24
CA2775603C (en) 2015-12-15
US8367098B2 (en) 2013-02-05
EP2485710A1 (en) 2012-08-15
WO2011044034A1 (en) 2011-04-14
MX2012004008A (es) 2012-09-07
CO6531457A2 (es) 2012-09-28
US20100256089A1 (en) 2010-10-07
MX337376B (es) 2016-02-29
ES2550815T3 (es) 2015-11-12
UA109117C2 (xx) 2015-07-27

Similar Documents

Publication Publication Date Title
BR112012008040A2 (pt) composição antimicrobiana aquosa
RS52323B (en) 2'-FLUORO-2'-DEOKSITETRAHIDROURIDINI KAO INHIBITORI CITIDIN DEAMINAZE
NO20092609L (no) Tannate salt of rasagiline
WO2007064954A3 (en) Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
BR112016005270A2 (pt) compostos de aza-piridona, composições farmacêuticas e seus usos
GT201200067A (es) "derivados de piromidona herbicida"
MX2011009847A (es) Agentes antihelminticos y su uso.
EA201100612A1 (ru) Новые производные 2-амидотиадиазола
MA39152A1 (fr) Cyclopentanes substitués en 1,2 utilisés comme antagonistes du récepteur d'orexine
WO2007028012A3 (en) Antibacterial 6'-n-modified 4,5-substituted aminoglycoside analogs
BR112016017311A2 (pt) Composição antimicrobiana, e, métodos para inibir uma ou mais infecções microbianas e para inibir infecção por hpv em um sujeito que necessita do mesmo
MA38865A1 (fr) Formulation comprenant un agent hypolipidémiant
BR112015016716A2 (pt) fio-máquina de aço acalmado com si com excelentes propriedades de fadiga, e mola que usa a mesma
NI201100149A (es) Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia.
MX2009007265A (es) Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion.
MA31229B1 (fr) Composés de 6-benzyl-2, 3,4, 7-tétrahydro-indolo [2, 3-c] quinoline utiles en tant qu'inhibiteurs de pde5
BR112013011268A2 (pt) curtimento não metálico
MX2009009490A (es) Profarmacos novedosos.
BR112013018938A2 (pt) agente antifúngico tópico
AR057081A1 (es) Medios para la fabricacion de cuero
MX2011013869A (es) Agentes antihelminticos y su uso.
MA32224B1 (fr) Derives de (pyrazolyl-carbonyl) imidazolidinone pour le traitement de maladies retrovirales
UY32757A (es) Derivados de pirazoles, su preparacion y su aplicacion terapeutica
MX2010001303A (es) Compuestos terapeuticos.
RS52725B (en) HERBICID FORMULATIONS

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 04/10/2010, OBSERVADAS AS CONDICOES LEGAIS.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 11A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2640 DE 10/08/2021 POR TER SIDO INDEVIDA.